Breaking News

Schreiner MediPharm Introduces Digital Display Label

Allows trial sponsors to eliminate time-consuming manual relabeling.

Author Image

By: Charlie Sternberg

Associate Editor

Schreiner MediPharm’s new Digital Display Label.

Schreiner MediPharm, a Germany-based global provider of functional label solutions for the healthcare industry, has introduced a novel solution for the digital marking of investigational drugs during clinical trials. The company’s Digital Display Label allows trial sponsors to eliminate time-consuming manual relabeling, enabling substantial process optimization and helping shorten a drug’s time to market. Schreiner MediPharm’s new Digital Display Label comprises a modular, reusable plastic ho...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters